(2023)
Intake of Fruit and Glycemic Control in Korean Patients with Diabetes Mellitus Using the Korea National Health and Nutrition Examination Survey.
ENDOCRINOLOGY AND METABOLISM.
38,
5
(2023)
Greater Severity of Steatosis Is Associated with a Higher Risk of Incident Diabetes: A Retrospective Longitudinal Study.
ENDOCRINOLOGY AND METABOLISM.
38,
4
(2022)
A double-blind, Randomized controlled trial on glucose-lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase-4 inhibitor therapy: REFIND study.
DIABETES OBESITY & METABOLISM.
24,
9
(2022)
The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018.
ENDOCRINOLOGY AND METABOLISM.
37,
3
(2022)
Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial.
DIABETES OBESITY & METABOLISM.
24,
4
(2022)
Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study).
DIABETES & METABOLISM JOURNAL.
46,
1
(2021)
Delayed heart rate recovery after exercise predicts development of metabolic syndrome: A retrospective cohort study.
JOURNAL OF DIABETES INVESTIGATION.
1,
1
(2020)
Association of Body Mass Index with the Risk of Incident Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality: A Community-Based Prospective Study.
ENDOCRINOLOGY AND METABOLISM.
35,
2
(2019)
Circulating calcium levels and the risk of type 2 diabetes: a systematic review and meta-analysis.
BRITISH JOURNAL OF NUTRITION.
122,
4
(2019)
Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study).
DIABETES OBESITY & METABOLISM.
22,
2
(2019)
Differing Associations between Fatty Liver and Dyslipidemia According to the Degree of Hepatic Steatosis in Korea.
Journal of Lipid and Atherosclerosis.
8,
2
(2019)
Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma.
THYROID.
29,
7
(2019)
The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome.
DIABETES & METABOLISM JOURNAL.
43,
4
(2019)
Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial.
DIABETES OBESITY & METABOLISM.
21,
1
(2018)
Utility of Serum Albumin for Predicting Incident Metabolic Syndrome According to Hyperuricemia.
DIABETES & METABOLISM JOURNAL.
42,
6
(2018)
Clinical outcomes of differentiated thyroid cancer patients with local recurrence or distant metastasis detected in old age.
Endocrinology and Metabolism.
33,
4
(2018)
Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
HEPATOLOGY.
68,
5
(2018)
Is decreased lung function associated with chronic kidney disease? A retrospective cohort study in Korea.
BMJ OPEN.
8,
4
(2018)
Increase in relative skeletal muscle mass over time and its inverse association with metabolic syndrome development: a 7-year retrospective cohort study.
CARDIOVASCULAR DIABETOLOGY.
17,
(2018)
Baseline level and change in serumalbumin concentration and the risk of incident type 2 diabetes.
JOURNAL OF DIABETES AND ITS COMPLICATIONS.
32,
1
단행본
(2023)
당뇨병학 6판. Textbook of DIABETES 6th edetion.
범문에듀케이션.
공동
학술회의논문
(2016)
LDL-C/apoB and HDL-C/apoA-1 ratio predict incident chronic kidney disease in a large apparently healthy cohort.
대만
(2015)
the protective effect of increment of serum uric acid levels on development of type 2 diabetes mellitus.
IDF World diabetes congress 2015.
캐나다
(2015)
High serum calcium were independently associated with a decreased risk of incident diabetes.
IDF The world diabetes congress 2015.
캐나다
(2015)
Association of lipid profile with the incidence of chronic kidney disease: a 7 year retrospective longitudinal study.
2015 international conference on diabetes and metabolism.
대한민국
(2014)
A multicentric, double-blind, randomised-controlled trial (RCT) of carnitine orotate complex in diabetic patients with non-alcoholic fatty liver disease (NAFLD).
European Association for the Study of Diabetes (유럽당뇨병학회).
오스트리아
